CencoraRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
CencoraPharmaceutical distributor formerly AmerisourceBergen, renamed in 2023. FY2025 revenue rose 9.3% to $321.3B, growth the company attributes largely to higher-priced new therapies including the GLP-1 class; US Healthcare Solutions revenue specifically cites diabetes and weight-loss labelled products.
All metrics are vertically resized to show how they've changed over time. They're not on the same Y-axis. This chart is meant to compare trends, not values.
Values normalized to 0-100 scale for comparison. Hover for actual values.